TY - JOUR
T1 - Probing the heterologous metabolism supporting 6-deoxyerythronolide B biosynthesis in Escherichia coli
AU - Zhang, Haoran
AU - Wang, Yong
AU - Boghigian, Brett
AU - Pfeifer, Blaine A.
PY - 2009/5
Y1 - 2009/5
N2 - Heterologous biosynthesis offers a new way to capture the medicinal properties presented by complex natural products. In this study, production of 6-deoxyerythronolide B (6dEB), the polyketide precursor to the antibiotic erythromycin, was used to probe the heterologous pathways needed for Escherichia coli-derived biosynthesis. More specifically, the heterologous proteins responsible for 6dEB production were varied by adjusting their respective gene dosage levels. In this way, heterologous components required for posttranslational modification, 6dEB biosynthesis, and substrate provision were adjusted in expression levels to observe the relative effect each has on final heterologous biosynthesis. The results indicate that both the biosynthetic and substrate provision heterologous proteins impact 6dEB formation to a greater extent when compared with posttranslational modification and suggest these components for future protein and metabolic engineering.
AB - Heterologous biosynthesis offers a new way to capture the medicinal properties presented by complex natural products. In this study, production of 6-deoxyerythronolide B (6dEB), the polyketide precursor to the antibiotic erythromycin, was used to probe the heterologous pathways needed for Escherichia coli-derived biosynthesis. More specifically, the heterologous proteins responsible for 6dEB production were varied by adjusting their respective gene dosage levels. In this way, heterologous components required for posttranslational modification, 6dEB biosynthesis, and substrate provision were adjusted in expression levels to observe the relative effect each has on final heterologous biosynthesis. The results indicate that both the biosynthetic and substrate provision heterologous proteins impact 6dEB formation to a greater extent when compared with posttranslational modification and suggest these components for future protein and metabolic engineering.
UR - http://www.scopus.com/inward/record.url?scp=77953566640&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77953566640&partnerID=8YFLogxK
U2 - https://doi.org/10.1111/j.1751-7915.2009.00099.x
DO - https://doi.org/10.1111/j.1751-7915.2009.00099.x
M3 - Article
C2 - 21261933
SN - 1751-7907
VL - 2
SP - 390
EP - 394
JO - Microbial Biotechnology
JF - Microbial Biotechnology
IS - 3
ER -